Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-10-017445)

Filing Details

Accession Number:: 0001181431-10-017445
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-19 13:00:00
Reporting Period:: 2010-03-18

Filing Date:: 2010-03-19
Accepted Time:: 2010-03-19 16:20:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1459450	Myriad Pharmaceuticals Inc.	MYRX	Pharmaceutical Preparations (2834)	263996918

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1191076	N Adrian Hobden	C/O Myriad Pharmaceuticals, Inc. 305 Chipeta Way Salt Lake City UT 84108	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-03-18	20,000	$4.41	134,782	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The shares were purchased in multiple transactions at prices ranging from $4.39 to $4.45 per share. The price reported above is the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.